OLANZAPINE

Generic: OLANZAPINE

Macleods Pharmaceuticals LimitedManufacturer
ORALRoute
OLANZAPINEActive Substance
2014-08-15Original Approval

OLANZAPINE is FDA application ANDA202862, sponsored by MACLEODS PHARMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
6,018 reports
2
OFF LABEL USE
4,342 reports
3
TOXICITY TO VARIOUS AGENTS
4,067 reports
4
DRUG INTERACTION
3,445 reports
5
WEIGHT INCREASED
2,864 reports
6
NAUSEA
2,802 reports
7
SOMNOLENCE
2,776 reports
8
CONDITION AGGRAVATED
2,405 reports
9
FATIGUE
2,383 reports
10
VOMITING
2,383 reports